GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » 4Front Ventures Corp (XCNQ:FFNT) » Definitions » Revenue

4Front Ventures (XCNQ:FFNT) Revenue : C$141.6 Mil (TTM As of Dec. 2023)


View and export this data going back to 2006. Start your Free Trial

What is 4Front Ventures Revenue?

4Front Ventures's revenue for the three months ended in Dec. 2023 was C$28.1 Mil. Its revenue for the trailing twelve months (TTM) ended in Dec. 2023 was C$141.6 Mil. 4Front Ventures's Revenue per Share for the three months ended in Dec. 2023 was C$0.04. Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was C$0.22.

Warning Sign:

4Front Ventures Corp revenue per share is in decline over the past 12 months.

During the past 12 months, the average Revenue per Share Growth Rate of 4Front Ventures was -13.00% per year. During the past 3 years, the average Revenue per Share Growth Rate was 12.30% per year. During the past 5 years, the average Revenue per Share Growth Rate was 15.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 13 years, 4Front Ventures's highest 3-Year average Revenue per Share Growth Rate was 31.80% per year. The lowest was 12.30% per year. And the median was 19.90% per year.


4Front Ventures Revenue Historical Data

The historical data trend for 4Front Ventures's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

4Front Ventures Revenue Chart

4Front Ventures Annual Data
Trend Apr14 Apr15 Apr16 Apr17 Apr18 Apr19 Dec20 Dec21 Dec22 Dec23
Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 18.64 73.83 133.84 146.26 130.72

4Front Ventures Quarterly Data
Jan19 Apr19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 37.82 41.56 40.78 31.12 28.15

Competitive Comparison of 4Front Ventures's Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, 4Front Ventures's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


4Front Ventures's Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, 4Front Ventures's Revenue distribution charts can be found below:

* The bar in red indicates where 4Front Ventures's Revenue falls into.



4Front Ventures Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$141.6 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


4Front Ventures  (XCNQ:FFNT) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


4Front Ventures Revenue Related Terms

Thank you for viewing the detailed overview of 4Front Ventures's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


4Front Ventures (XCNQ:FFNT) Business Description

Traded in Other Exchanges
Address
5060 North 40th Street, Suite 120, Phoenix, AZ, USA, 85018
4Front Ventures Corp is a Canadian-based company. It is engaged in the cultivation, processing, extracting, manufacturing, and distribution of cannabis products. It operates in two segments: THC Cannabis and CBD Wellness. The THC Cannabis segment engages in the production and cultivation of THC cannabis, manufacturing and distribution of cannabis products to own dispensaries and third-party retail customers. The CBD Wellness segment encompasses the production and sale of CBD products to third-party customers.

4Front Ventures (XCNQ:FFNT) Headlines

No Headlines